H. Graffner

3.7k total citations
74 papers, 2.9k citations indexed

About

H. Graffner is a scholar working on Surgery, Gastroenterology and Oncology. According to data from OpenAlex, H. Graffner has authored 74 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 24 papers in Gastroenterology and 18 papers in Oncology. Recurrent topics in H. Graffner's work include Helicobacter pylori-related gastroenterology studies (25 papers), Gastroesophageal reflux and treatments (17 papers) and Gastrointestinal motility and disorders (13 papers). H. Graffner is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (25 papers), Gastroesophageal reflux and treatments (17 papers) and Gastrointestinal motility and disorders (13 papers). H. Graffner collaborates with scholars based in Sweden, United States and United Kingdom. H. Graffner's co-authors include J Oscarson, Michael Camilleri, Leif Rikner, K.‐G. Tranberg, Björn Ohlsson, Henrik Ekberg, Jeffrey W. Milsom, M. Ekelund, R. Håkanson and Gert Lindell and has published in prestigious journals such as Gastroenterology, Annals of Surgery and American Journal of Obstetrics and Gynecology.

In The Last Decade

H. Graffner

73 papers receiving 2.8k citations

Peers

Countries citing papers authored by H. Graffner

Since Specialization

Citations

This map shows the geographic impact of H. Graffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Graffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Graffner more than expected).

Fields of papers citing papers by H. Graffner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Graffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Graffner. The network helps show where H. Graffner may publish in the future.

Co-authorship network of co-authors of H. Graffner

This figure shows the co-authorship network connecting the top 25 collaborators of H. Graffner. A scholar is included among the top collaborators of H. Graffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Graffner. H. Graffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of conventional and a novel colonic‐release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea 2016 ·United European Gastroenterology Journal ·Richard Appleby, Antal Bajor, (unknown), H. Graffner, Magnus Simrén, (unknown), Julian R.F. Walters	12
2	Specific inhibition of bile acid transport alters plasma lipids and GLP-1 2015 ·BMC Cardiovascular Disorders ·Mats Rudling, Michael Camilleri, H. Graffner, Jens J. Holst, Leif Rikner	45
3	Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis 2015 ·Journal of Hepatology ·Anna Baghdasaryan, Claudia Fuchs, Christoph H. Österreicher, Ursula Lemberger, Emina Halilbasic, Ingrid Påhlman, H. Graffner, Elisabeth Krones, Peter Fickert, Annika Wahlström, Marcus Ståhlman, G. Paumgartner, Hanns–Ulrich Marschall, Michael Trauner	143
4	Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation 2011 ·The American Journal of Gastroenterology ·Banny S. Wong, Michael Camilleri, Sanna McKinzie, Duane D. Burton, H. Graffner, Alan R. Zinsmeister	114
5	A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation 2011 ·The American Journal of Gastroenterology ·William D. Chey, Michael Camilleri, Lin Chang, Leif Rikner, H. Graffner	140
6	S1299 The IBAT Inhibitor A3309 – A Promising Treatment Option for Patients With Chronic Idiopathic Constipation (Cic) 2010 ·Gastroenterology ·Magnus Simrén, Hasse Abrahamsson, Antal Bajor, H. Graffner	6
7	Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study 2009 ·BMC Gastroenterology ·Claudia Peña Rossi, Stephen B. Hanauer, (unknown), John O. Hunter, Ira Shafran, H. Graffner	37
8	Clinical trial: a multicentre, randomized, double‐blind, placebo‐controlled, dose‐finding, phase II study of subcutaneous interferon‐β‐1a in moderately active ulcerative colitis 2008 ·Alimentary Pharmacology & Therapeutics ·(unknown), Stefan Schreiber, (unknown), (unknown), Julián Panés, Daniel Rachmilewitz, (unknown), В. И. Симаненков, (unknown), H. Graffner	40
9	Review article: The role of the gut flora in health and disease, and its modification as therapy 2002 ·Alimentary Pharmacology & Therapeutics ·AL Hart, (unknown), (unknown), H. Graffner, H. Glise, P. Falk, (unknown)	11
10	The role of the gut flora in health and disease, and its modification as therapy 2002 ·Alimentary Pharmacology & Therapeutics ·A Hart, Andrew J. Stagg, (unknown), H. Graffner, H. Glise, P. Falk, Michael A. Kamm	71
11	Prospective randomized multicentre study of laparoscopic versus open appendicectomy 1999 ·British journal of surgery ·Anders Hellberg, Claes Rudberg, E Kullman, Lars Enochsson, G Fenyö, H. Graffner, B. Hallerbäck, B. Johansson, B Anderberg, Jörgen Wenner, Ivar Ringqvist, S. Sörensen	139
12	Acute Effects of High-Dose Intragastric Nicotine on Mucosal Defense Mechanisms An Analysis of Nicotine, Prostaglandin E2, Phospholipase A2, and Phospholipids 1997 ·Digestive Diseases and Sciences ·Gert Lindell, Klaus Bukhave, Ingela Lilja, (unknown), H. Graffner	10
13	A financial analysis of laparoscopic and open cholecystectomy 1995 ·Surgical Endoscopy ·Jörgen Wenner, H. Graffner, Gert Lindell	15
14	On the Natural History of Peptic Ulcer 1994 ·Scandinavian Journal of Gastroenterology ·Gert Lindell, Fuat Celebioglu, Christer Staël von Holstein, H. Graffner	12
15	Budesonide versus prednisolone retention enemas in active distal ulcerative colitis 1994 ·Alimentary Pharmacology & Therapeutics ·Robert Löfberg, Ole Østergaard Thomsen, Ebbe Langholz, R Schiöler, Åke Danielsson, Ole B. Suhr, H. Graffner, Lars Påhlman, Peter Matzen, J Møller-Petersen, Lars Halvorsen, N Hovdenak, Roger Wïllén, Tore Persson, (unknown)	87
16	Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors 1993 ·Diseases of the Colon & Rectum ·G. Dave Singh, H. Graffner, Jeffrey W. Milsom, Irshad H. Chaudry	2
17	Acute Effects of Smoking during Modified Sham Feeding in Duodenal Ulcer Patients: An Analysis of Nicotine, Acid Secretion, Gastrin, Catecholamines, Epidermal Growth Factor, Prostaglandin E₂, and Bile Acids 1993 ·Scandinavian Journal of Gastroenterology ·Gert Lindell, (unknown), D. Chen, Ebba Nexø, (unknown), Klaus Bukhave, H. Graffner	58
18	Anaesthetic Agents Suppress Basal and Stimulated Gastric Acid Secretion.: Are Intramural Neurons Involved? 1991 ·Scandinavian Journal of Gastroenterology ·H. Graffner, M. Ekelund, R. Håkanson	5
19	<i>Helicobacter pylori, </i>Smoking and Gastroduodenitis 1991 ·Digestion ·Gert Lindell, (unknown), Claës Schalén, (unknown), H. Graffner	7
20	Intrarectal Ultrasonography in Rectal Cancer Staging and in the Evaluation of Pelvic Disease Clinical Uses of Intrarectal Ultrasound 1990 ·Annals of Surgery ·Jeffrey W. Milsom, H. Graffner	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact